Hepatitis C virus (HCV) is a major cause of community-acquired viral hepatitis. The HCV genome is a linear, positive-strand RNA molecule of approximately 9,500 nucleotides and encodes a polyprotein of about 3,000 amino acids. Several stretches of amino acids in the HCV polyprotein share significant similarity with flavivirus and pestivirus proteins. Therefore, HCV is considered to be distantly related to these virus groups. The goal of this project is to increase our understanding of the molecular biology of this important human pathogen. Prototype strains of the various genotypes of HCV, including some of those discovered in this laboratory, are being biologically amplified in chimpanzees and further characterized. Pools of virus-contaimng plasma have been packaged and distributed for further characterization and use as challenge inocula in studies of passive and active immunoprophylaxis, etc. Two full-length cDNA clones of HCV (genotypes 1a and 1b) have been constructed and transcribed RNA used to transmit hepatitis C to chimpanzees by in vivo hepatic transfection. The genotype 1b clone was constructed as a chimera from the infectious cDNA clone of genotype 1a and PCR-amplified sequences from genotype 1b. Four chimpanzees, transfected with genotype 1a or 1b infectious cDNA clones are being followed to determine the natural history of infection. The HVS is monitoring the humoral immune response to these monoclonal viruses and Dr. Frank Chisari (Scripps Institute) is monitoring the cellular immune responses. Upon completion of this study, a detailed analysis of the immune response to experimental HCV infection should be available, a first step toward the development of a rational HCV vaccine. In addition, the availability of infectious cDNA clones of HCV has permitted for the first time a mutational analysis of genomic regions. For example, the 3' non-coding region (NCR) of HCV is complex, consisting of a variable region, a poly U-UC tract and a highly conserved terminal 3' region, but its function is unknown. Individual portions of the 3' NCR have been deleted from the full-length clone and the resultant deletion mutant clones inoculated into chimpanzees by intrahapatic transfection. Certain regions of the NCR have already been identified as critical for in vivo replication of HCV. By this means, a complete analysis of the 3' NCR region will be completed. Similar analyses of other regions of the HCV genome will be carried out also.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Intramural Research (Z01)
Project #
1Z01AI000570-09
Application #
6098973
Study Section
Special Emphasis Panel (LID)
Project Start
Project End
Budget Start
Budget End
Support Year
9
Fiscal Year
1998
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Kyuregyan, Karen K; Poleschuk, Valentina F; Zamyatina, Natalya A et al. (2005) Acute GB virus B infection of marmosets is accompanied by mutations in the NS5A protein. Virus Res 114:154-7
Meunier, Jean-Christophe; Engle, Ronald E; Faulk, Kristina et al. (2005) Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci U S A 102:4560-5
Bukh, Jens (2004) A critical role for the chimpanzee model in the study of hepatitis C. Hepatology 39:1469-75
Nam, Jae-Hwan; Faulk, Kristina; Engle, Ronald E et al. (2004) In vivo analysis of the 3' untranslated region of GB virus B after in vitro mutagenesis of an infectious cDNA clone: persistent infection in a transfected tamarin. J Virol 78:9389-99
Sakai, Akito; Claire, Marisa St; Faulk, Kristina et al. (2003) The p7 polypeptide of hepatitis C virus is critical for infectivity and contains functionally important genotype-specific sequences. Proc Natl Acad Sci U S A 100:11646-51
Bartosch, Birke; Bukh, Jens; Meunier, Jean-Christophe et al. (2003) In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A 100:14199-204
Corbet, Sylvie; Bukh, Jens; Heinsen, Anja et al. (2003) Hepatitis C virus subtyping by a core-envelope 1-based reverse transcriptase PCR assay with sequencing and its use in determining subtype distribution among Danish patients. J Clin Microbiol 41:1091-100
Bukh, Jens; Christensen, Erik; Krogsgaard, Kim (2003) [Treatment and prevention of hepatitis C--progress and challenges. The Danish Society of Hepatology] Ugeskr Laeger 165:1233
Bukh, Jens; Pietschmann, Thomas; Lohmann, Volker et al. (2002) Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees. Proc Natl Acad Sci U S A 99:14416-21
Ma, Xiaoying; Forns, Xavier; Gutierrez, Robin et al. (2002) DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice. Vaccine 20:3263-71

Showing the most recent 10 out of 21 publications